BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September

Day

• 1
• 2
• 3
• 4
• 6
• 7
• 8
• 9
• 10
• 11
• 13
• 14
• 15
• 16
• 17
• 18
• 20
• 21
• 22
• 23
• 24
• 25

• 

  Neuroscience

  Novartis drops $125M for Sironax’s tech to cross blood-brain barrier

  Novartis stands alongside Big Pharma peers that have similarly invested in technologies to penetrate the blood-brain barrier, including GSK, Roche and Eli Lilly.

  September 17, 2026

   · 

  2 min read

   · 

  Tristan Manalac
• Press Releases

  Shane Schaffer, Cingulate Chairman & CEO to Present “SMART Launch” Approach at Indegene Digital Summit: Rethinking Commercialization for Emerging Pharma

  September 17, 2026

   · 

  7 min read
• Press Releases

  Recludix Pharma to Present at the Stifel 2026 Virtual Immunology and Inflammation Forum

  September 17, 2026

   · 

  1 min read
• Press Releases

  Aerska Appoints Laura Sepp-Lorenzino to Scientific Advisory Board

  September 17, 2026

   · 

  2 min read
• Press Releases

  Matisse Pharmaceuticals closed Series A financing round to advance isupartob sodium through phase 2 clinical development

  September 17, 2026

   · 

  3 min read
• Press Releases

  Hemab Therapeutics Announces First Participant Dosed in Phase 1 Clinical Trial of HMB-003, an Investigational Therapy for the Management of Heavy Menstrual Bleeding

  September 17, 2026

   · 

  7 min read
• Press Releases

  Quince Therapeutics to Host Virtual KOL Event to Discuss the Current Treatment Landscape for PH-ILD and BOS and the Role for LAM-001 as a Potential Therapeutic Option on September 28, 2026

  September 17, 2026

   · 

  10 min read
• Press Releases

  Artiva Biotherapeutics to Participate in the Stifel 2026 Virtual Immunology and Inflammation Forum

  September 17, 2026

   · 

  3 min read
• Press Releases

  Catheter Precision Expands LockeT Commercialization Across Latin America Following Successful Launch in Brazil

  September 17, 2026

   · 

  4 min read
• Press Releases

  Adaptive Biotechnologies Announces Update to NCCN Guidelines® for Multiple Myeloma, Strengthening MRD Testing Recommendations and Specifically Referencing clonoSEQ®

  September 17, 2026

   · 

  7 min read